A technical trade short term AartiaDrugPrice is taking support multiple times at a single support line.....buying zone 453-458.....Target 1 is 543-554 and Target 2 is 604-608....sl closing below 436...only for educational purposes and not any recommendations.....Longby Prakash_Patil2301Dec 24, 20241
Aarti Drugs - Key Levels to WatchAarti Drugs - Key Levels to Watch 🔍 Aarti Drugs has shown some recovery after restoring production at its Tarapur unit, as per recent filings. Here’s the technical outlook: 1.Fibonacci Retracement Levels: Resistance at 0.618 (₹593) and 0.5 (₹676). Immediate support near 0.786 (₹476). 2.Volume Profile: High activity seen between ₹450-₹500. Sustained support in this zone is crucial. 3.RSI: Current RSI shows a slight bullish divergence—monitor for a potential rebound. Levels of Interest: Upside Potential: ₹593 (618 Fib) and ₹676 (0.5 Fib). Downside Support: ₹476 (786 Fib) and ₹450 (volume support zone). Stay cautious as the stock consolidates. Monitor for clear directional moves above or below these levels. Nby AngshumanSaikiaNov 19, 20241
Aarti drug breakout structureAarti drug can double from here with in few years. Sl below the trend line. Chart is self explanatory. Please follow the price action & take the trade as per your appetite. The information provided here is only for educational purpose. The information provided here is not intended to be any kind of financial advice, investment advice, and trading advice. Investment in stock market is very risky and trading stocks, options and other securities involve risk. The risk of loss in stock market can be substantial. Moreover, I am not a SEBI registered analyst, so before taking any decision or before investing in any Share consult your financial advisor and also do your analysis and research. Request your support and engagement by liking and commenting & follow to provide encouragement.NLongby peacemaker202444Aug 20, 20245
aarti drugThe company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.NLongby TradernawabApr 15, 20234
Triangle Breakout After a Long Time...AARTI DRUGS try to attempt a Triangle Breakout after a long time. After a successful breakout you can watch for Swing Trade. Next resistence is at 800-900.NLongby thecapitalmarketsAug 20, 20241
Aarti drugs Aarti drugs gave monthly breakout Buy - 520-530 Stoploss - 425 Final Target - 1400 NLongby YashMehta_Jul 5, 20246
Aarti Drugs Bullish, Kindly do your own studyThis stock is looking bullish. Please do your study before taking any decision. Monthly price is above 50 EMA and also above 5 EMA After big rally ABC correction seems to be over New impulse could be started. 1st wave has been completed and in 2nd wave also ABC seems to be over Monthly MACD PCO above zero line Weekly MACD PCO Weekly RSI is above 50 Weekly price is above 50 EMA and golden crossover is happening Daily price has given breakout Daily RSI is above 60 Daily ADX Volume is above averageNLongby VR_SecuritiesJun 8, 20242
AARTIDRUGS 1DAYNICE BREAKOUT WAIT FOR THE RETEST I Am Not SEBI Registered Analyst. All Post and Levels Posting is only for educational and knowledge purpose. I Am not responsible for your any kind of loss or profit. No Claim, All Rights Reserved.‼️NLongby saimandaliJun 7, 20240
Aarti Drugs giving signs of pennant Breakout. Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. ADL engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Aarti Drugs Limited (ADL) CMP is 495.70. The positive aspects of the company are Company with Low Debt, Growth in Quarterly Net Profit with increasing Profit Margin, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, and Mutual Funds Increased Shareholding. The Negative aspects of the company are Decline in Quarterly Net Profit, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding. Entry can be taken after closing above 503 Targets in the stock will be 519 and 531. The long-term target in the stock will be 549 and 568. Stop loss in the stock should be maintained at Closing below 456. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.NLongby Happy_Candles_InvestmentMay 28, 20241
AARTIDRUGSPossible upside in Aarti Drugs as in wave 3 of Elliott Wave theory. May reach upto 950 by Dec'24.NLongby rahultoppo07May 14, 2024118
AARTI DRUGS LTDAARTI DRUGS LTD look good above 512 big moves possible one con is less volume if volume increases from 1m to 3m it is good sign to buy Nby kartikhereApr 29, 20243
Aarti drugs ready for next moveAarti drugs buy above 495 stop loss 468 tgt 1 530 tgt 2 550NLongby yogesharora2409Updated Jan 26, 202426
Aarti drugs Breakout Aarti drugs given daily chart Trendline Breakout then consolidation,now ready for Big move NLongby bagherwalJan 9, 20241
Long AARTIDRUGSAarti Drugs is engaged in the manufacturing and marketing in active Pharmaceutical Ingredients , Pharma Intermediates and Specialty Chemicals. Having a pharma company always has its advantages now due to current ever increasing health issues. I expect a 10% move in the next 6 months.NLongby kiranmammen1999Jan 6, 20241
Wave 3 in AARTIDRUGS can push price up by 80%!!The Stock witnessed a five-wave impulsive rise beginning in March 2023 and ending in July 2023. The impulse move led to a 105% rally in the stock in a matter of just 5 months. Since the completion of the wave 1 in July however, the stock went into the corrective wave 2 structure between July-October. The corrective phase can be marked as an Elliot wave Zig-zag(ABC) and led to a 50% retracement of the wave 1. This phase ended in October and between October-November the stock displayed a slow moving leading diagonal as the first sign of reversal from the bottom of INR 444.This tiny diagonal is the only starting piece of the massive leg that is yet to unfold in the stock, taking it towards the INR 900 mark. The diagonal and its correction can be labeled as wave i&ii of 3 respectively and now the stock has "jump-started" the wave iii of 3 on 18DEC with a +4.2% closing alongside uptick in volumes. Upon successfully surpassing INR500 level, the stock shall be at the INR550 in 'very quick move'. INR 900 is the projected target region for the Wave 3. On the downside INR 470 can be used as 'SL'. Note*- The views expressed are based on personal opinions and observations. Please do your own research before making any trading/investing decisions.NLongby neeraj_2_sharmaUpdated Dec 19, 20232
Easy Guess Comment Whats going to happen nextSo easy to predict whats going to happen next. Forming the rounding bottom. NLongby Chart_analyser_NJSep 6, 20233
Resistance Breakout Please look into the chart for a detailed understanding. Consider these for short-term & swing trades with 2% profit. For BTST trades consider booking target for 1% - 2% For long-term trades look out for resistance drawn above closing. Please consider these ideas for educational purposeNLongby Breakout-IdeasJul 24, 20236
AARTI DRUGS reday for breakout upside Aarti drugs making Inverter head & sholder pattern, if break out it this pattern than Target to upside 700 level & SL to be bellow 438. Only for education purposeNLongby pnjakh1984Jul 16, 20231
Aarti DrugsShowing signs of reversal and crossing over of 5,20,50 SMA on monthly time frame shows positivity. Safe entry would be above 515 where candle enters 1/1 damn angle and breaks out of the important Gann levels NLongby happyvegan10Jul 12, 2023110
Breakout happend.Keep your risk and reward ratio according to your preferance. This is for educational purpose. Do your own research before investing.NLongby HV090604Jul 12, 20231
AARTIDRUGSBuy above :- 471 Stop loss :- 409 Target:- 530 Time :- 45 trading days Aarti Drugs Limited is a pharmaceutical company which manufactures bulk drugs and specialty chemicals.Nby zaverimeet84May 16, 20231
Aarti Drugs looking to dazzleAarti drugs limited is a pharmaceutical & biotechnology company engaged in manufacturing of APIs (Active Pharmaceutical Ingredients), Pharma Intermediates & Specialty chemicals. With strong Research and Development (R&D) and GMP certified manufacturing units the company aims to provide quality and effective solutions to their clients PAN India. CMP of the stock is 457.80. Negative of the company is declining annual net profit. Positives of the company are low debt, improving quarterly net profit and FIIs and MFs are increasing stake. Entry in the stock can be taken after closing above 471. Target will be 512 & 531. Long term target will be 600+. Stop loss in the stock should be kept at the closing below 396. NLongby Happy_Candles_InvestmentMay 2, 20230
Doubtful Breakout Doubtful #breakout so i will prefer to wait for pullback for fresh entryNLongby PrasantaPMay 2, 20230